Quoc Le-Nguyen - 30 Oct 2024 Form 4 Insider Report for 89bio, Inc. (ETNB)

Signature
/s/ Ryan A. Murr, as attorney-in-fact for Quoc Le-Nguyen
Issuer symbol
ETNB
Transactions as of
30 Oct 2024
Net transactions value
-$226,995
Form type
4
Filing time
01 Nov 2024, 16:01:03 UTC
Previous filing
10 Sep 2024
Next filing
16 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Sale $226,995 -27,955 -13% $8.12 187,796 30 Oct 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 1, 2024.
F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.25. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Remarks:

Chief Technical Operations Officer